BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

60 related articles for article (PubMed ID: 15555554)

  • 21. Acquisition of Fas resistance by Fas receptor mutation in a childhood B-precursor acute lymphoblastic leukemia cell line, MML-1.
    Inaba H; Shimada K; Zhou YW; Ido M; Buck S; Yonehara S; Kaplan J; Komada Y
    Int J Oncol; 2005 Aug; 27(2):573-9. PubMed ID: 16010441
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Synergistic antitumor effects of lenalidomide and rituximab on mantle cell lymphoma in vitro and in vivo.
    Zhang L; Qian Z; Cai Z; Sun L; Wang H; Bartlett JB; Yi Q; Wang M
    Am J Hematol; 2009 Sep; 84(9):553-9. PubMed ID: 19565649
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The in vitro antitumor effect and in vivo tumor-specificity distribution of human-mouse chimeric antibody against transferrin receptor.
    Qing Y; Shuo W; Zhihua W; Huifen Z; Ping L; Lijiang L; Xiaorong Z; Liming C; Daiwen X; Yu H; Wei X; Min F; Zuohua F; Guanxin S
    Cancer Immunol Immunother; 2006 Sep; 55(9):1111-21. PubMed ID: 16341531
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Apoptosis of multiple myeloma cells induced by agonist monoclonal antibody against human CD28.
    Qiu YH; Sun ZW; Shi Q; Su CH; Chen YJ; Shi YJ; Tao R; Ge Y; Zhang XG
    Cell Immunol; 2005; 236(1-2):154-60. PubMed ID: 16188246
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The in vitro biological activity of the HLA-DR-binding clinical IgG4 antibody 1D09C3 is a consequence of the disruption of cell aggregates and can be abrogated by Fab arm exchange.
    Hansen K; Ruttekolk IR; Glauner H; Becker F; Brock R; Hannus S
    Mol Immunol; 2009 Oct; 46(16):3269-77. PubMed ID: 19699529
    [TBL] [Abstract][Full Text] [Related]  

  • 26. FTY720 induces apoptosis in multiple myeloma cells and overcomes drug resistance.
    Yasui H; Hideshima T; Raje N; Roccaro AM; Shiraishi N; Kumar S; Hamasaki M; Ishitsuka K; Tai YT; Podar K; Catley L; Mitsiades CS; Richardson PG; Albert R; Brinkmann V; Chauhan D; Anderson KC
    Cancer Res; 2005 Aug; 65(16):7478-84. PubMed ID: 16103102
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Preclinical antilymphoma activity of a humanized anti-CD40 monoclonal antibody, SGN-40.
    Law CL; Gordon KA; Collier J; Klussman K; McEarchern JA; Cerveny CG; Mixan BJ; Lee WP; Lin Z; Valdez P; Wahl AF; Grewal IS
    Cancer Res; 2005 Sep; 65(18):8331-8. PubMed ID: 16166310
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Anti-CD74 antibody-doxorubicin conjugate, IMMU-110, in a human multiple myeloma xenograft and in monkeys.
    Sapra P; Stein R; Pickett J; Qu Z; Govindan SV; Cardillo TM; Hansen HJ; Horak ID; Griffiths GL; Goldenberg DM
    Clin Cancer Res; 2005 Jul; 11(14):5257-64. PubMed ID: 16033844
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Honeybee venom induces calcium-dependent but caspase-independent apoptotic cell death in human melanoma A2058 cells.
    Tu WC; Wu CC; Hsieh HL; Chen CY; Hsu SL
    Toxicon; 2008 Aug; 52(2):318-29. PubMed ID: 18602939
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Construction of a conventional non-radioisotope method to quantify HM1.24 antigens: correlation of HM1.24 levels and ADCC activity of the humanized antibody against HM1.24.
    Kawai S; Koishihara Y; Iida S; Ozaki S; Matsumoto T; Kosaka M; Yamada-Okabe H
    Leuk Res; 2006 Aug; 30(8):949-56. PubMed ID: 16473407
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The single antigen expressing lines (SALs) concept: an excellent tool for screening for HLA-specific antibodies.
    Zoet YM; Eijsink C; Kardol MJ; Franke-van Dijk ME; Wilson GL; de Paus R; Mickelson E; Heemskerk M; van den Elsen PJ; Claas FH; Mulder A; Doxiadis II
    Hum Immunol; 2005 May; 66(5):519-25. PubMed ID: 15935889
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Withaferin A induces apoptosis by activating p38 mitogen-activated protein kinase signaling cascade in leukemic cells of lymphoid and myeloid origin through mitochondrial death cascade.
    Mandal C; Dutta A; Mallick A; Chandra S; Misra L; Sangwan RS; Mandal C
    Apoptosis; 2008 Dec; 13(12):1450-64. PubMed ID: 18987975
    [TBL] [Abstract][Full Text] [Related]  

  • 33. HLA-E/human beta2-microglobulin transgenic pigs: protection against xenogeneic human anti-pig natural killer cell cytotoxicity.
    Weiss EH; Lilienfeld BG; Müller S; Müller E; Herbach N; Kessler B; Wanke R; Schwinzer R; Seebach JD; Wolf E; Brem G
    Transplantation; 2009 Jan; 87(1):35-43. PubMed ID: 19136889
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Structured to reduce the mitogenicity of anti-CD3 antibody based on computer-guided molecular design.
    Lv M; Li Y; Yu M; Sun Y; Lin Z; Qiao C; Luo Q; Gu X; Huang Y; Feng J; Shen B
    Int J Biochem Cell Biol; 2007; 39(6):1142-55. PubMed ID: 17446118
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A new anticancer glycolipid monoclonal antibody, SC104, which directly induces tumor cell apoptosis.
    Durrant LG; Harding SJ; Green NH; Buckberry LD; Parsons T
    Cancer Res; 2006 Jun; 66(11):5901-9. PubMed ID: 16740730
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The GD2-specific 14G2a monoclonal antibody induces apoptosis and enhances cytotoxicity of chemotherapeutic drugs in IMR-32 human neuroblastoma cells.
    Kowalczyk A; Gil M; Horwacik I; Odrowaz Z; Kozbor D; Rokita H
    Cancer Lett; 2009 Aug; 281(2):171-82. PubMed ID: 19339105
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cellular expression or binding of desLys58-beta2 microglobulin is not dependent on the presence of the tri-molecular MHC class I complex.
    Wang M; Corlin DB; Heegaard NH; Claesson MH; Nissen MH
    Scand J Immunol; 2008 Feb; 67(2):105-12. PubMed ID: 18069937
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Development of novel tetravalent anti-CD20 antibodies with potent antitumor activity.
    Li B; Shi S; Qian W; Zhao L; Zhang D; Hou S; Zheng L; Dai J; Zhao J; Wang H; Guo Y
    Cancer Res; 2008 Apr; 68(7):2400-8. PubMed ID: 18381448
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A novel dietary triterpene Lupeol induces fas-mediated apoptotic death of androgen-sensitive prostate cancer cells and inhibits tumor growth in a xenograft model.
    Saleem M; Kweon MH; Yun JM; Adhami VM; Khan N; Syed DN; Mukhtar H
    Cancer Res; 2005 Dec; 65(23):11203-13. PubMed ID: 16322271
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Caspase-independent killing of Burkitt lymphoma cell lines by rituximab.
    Daniels I; Abulayha AM; Thomson BJ; Haynes AP
    Apoptosis; 2006 Jun; 11(6):1013-23. PubMed ID: 16544097
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.